Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Summit for Clinical Ops Executives Puts Spotlight on the Cell & Gene Therapies Supply Chain & Medical Device Trials, February 11-14, 2024, Orlando, FL


Over 3,300 executives will convene to explore solutions for various aspects of planning and managing clinical trials.

NEEDHAM, Mass., Nov. 2, 2023 /PRNewswire-PRWeb/ — In response to the rapid expansion of the cell and gene therapy (CGT) market valued at $7.28 billion in 2022 and a predicted compound annual growth rate (CAGR) of 26.6% from 2023 to 2030 (as reported by MarketsandMarkets™), Cambridge Healthtech Institute (CHI) delves into the diverse clinical supply chain infrastructure designed for today’s approved Cell and Gene Therapies (CGT), as well as supply strategies for those presently engaged in clinical trials, at its 15th annual SCOPE: Summit for Clinical Ops Executives, taking place February 11-14, 2024, in Orlando, FL, and online.

The SCOPE Summit brings together over 3,300 executives and clinical operations experts. All understand the necessity of making improvements to the clinical supply chain which is essential to meet the growing complexity of clinical trials, particularly in the context of rapidly evolving cell and gene therapies that are reshaping treatments and challenging established supply chain paradigms.

Mary Ann Brown, Executive Director of Conferences at CHI, emphasized the need to better manage the clinical supply chain and maintain resiliency, noting we can now apply new tools and get it right for patients.

The summit will feature a dedicated stream on Clinical Supply, encompassing 2 distinct conferences: “Data Technology for End-to-End Clinical Supply Management” and “Clinical Supply Chain Strategies to Align Process, Products and Patients.” These programs will host numerous presentations, covering topics such as digitalization, IRT integration, data flows, forecasting, tracking, reducing costs, operationalizing DEI efforts through outsourcing and partnerships, among other areas of interest. Additionally, each conference will offer breakfast & lunch presentations and interactive breakout discussions. (https://www.scopesummit.com/Clinical-Supply-Management)

Furthermore, the event brings back its Medical Device Trials conferences focusing on trial design, operations, regulations, quality, and data management. (https://www.scopesummit.com/medical-devices)

With experts from the FDA, AbbVie, Eli Lilly, Merck & Co., Moderna, Pfizer and other leaders sharing insights, case studies and data, highlights of SCOPE include:

  • 24 Additional Conferences at the core of driving innovation in clinical trials and digital health
  • Plenary Keynote Sessions on modernizing trials with FDA and generative AI
  • Exhibit Hall with 200+ Companies showcasing cutting-edge products and services
  • Best of Show Award, Site Innovation Award, Participant Engagement Award, and Site Innovation Award

For more information, visit https://www.scopesummit.com.

Writers and editors are invited to attend. To request a press pass, please visit https://www.healthtech.com/press.

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, and academic organizations. CHI’s portfolio of products includes CHI Conferences, Barnett Educational Services, Evaluating Biopharma, ClinEco and Healthtech Publishing, which includes publications such as Bio-IT World, Clinical Informatics News, and Diagnostics World, as well as numerous e-newsletters. Founded in 1992, CHI strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with a heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. The executive team has a combined 170+ years of experience and drives the CHI portfolio to deliver cutting-edge information and the most up-to-date research.

Media Contact

Rich Handy, Cambridge Healthtech Institute (CHI), +1 781-972-5400, [email protected], www.scopesummit.com

SOURCE Cambridge Healthtech Institute (CHI)

AHN Cancer Institute Unveils State-of-the-Art Skin Cancer Center at West Penn Hospital


The AHN Skin Cancer Center is also home to the region’s first and only VECTRA WB360 Whole Body Imaging System.

VECTRA WB360 captures patient images using 92 high-definition cameras and special flash lighting, generating a single 3D avatar of the entire body. Digitized records of the patient’s skin allow clinicians to examine individual moles and lesions, and monitor changes in size, color, and shape over time by comparing subsequent VECTRA imaging to the baseline avatar.

The entire imaging process takes just a few minutes.

The VECTRA WB360 technology at West Penn Hospital is one of 15 such devices in operation in the United States. West Penn is in Pittsburgh’s Bloomfield neighborhood.

“Dermatology and skin cancer medicine are visual fields – having better images means better care for our patients, and more timely detection of suspicious abnormalities,” said Howard D. Edington, MD, surgical oncologist and director of the AHN Skin Cancer Center. “By combining artificial intelligence with the clinical expertise of our physicians, we can provide more thorough preventive care.”

VECTRA WB360 includes software that compares the patient’s images with a set of images in the VECTRA database that have a known diagnosis. An algorithm then calculates a score to quantify the risk or biological concern of the lesion, helping to guide the clinician as results are analyzed.

Patients who undergo VECTRA imaging at the Skin Cancer Center will be notified after a review of the imaging if any of the skin lesions warrant a biopsy or follow-up care.

“The new Skin Cancer Center is a true testament to Highmark Health’s Living Health promise,” said David L. Bartlett, MD, Chair, AHN Cancer Institute. “With more Americans being diagnosed with skin cancer than all other cancers combined, the need for highly accessible and advanced technology to provide routine surveillance to patients is critical to catch the disease as early as possible.”

Clinical and translational research conducted at the Skin Cancer Center will focus on additional new medical therapies, real-time diagnostic technologies that help doctors catch cancer at its earliest stages, and identifying novel biomarkers that can be used to develop precision medicine that targets cancers’ genetic makeup.

According to the Skin Cancer Foundation, in the U.S., more than 9,500 people are diagnosed with skin cancer every day, and more than two people die of the disease every hour.

About 1 in 50 Americans will develop melanoma during their lifetimes, and its incidence has doubled over the past 30 years, according to the Melanoma Research Alliance. About 166,000 Americans are diagnosed with melanoma annually and about 7,000 may die from the disease. Skin cancers, including melanoma, are strongly connected with exposure to ultraviolet radiation from the sun or tanning beds.

The AHN Cancer Institute also offers innovative treatments for skin cancers, such as oncolytic virus therapy for inoperable melanoma. Treatment is delivered directly into the patient’s tumor, and the therapy acts in concert with the body’s immune system to fight the cancer.

The development of the Skin Cancer Center was funded by a generous donation from the West Penn Hospital Foundation.

“Thanks to generous philanthropy from the West Penn Hospital Foundation, the AHN Skin Cancer Center is now an important regional asset in the fight against cancer,” said Mitch Beckman, Highmark Health’s Chief Development Officer. “The new technology and services offered at the Skin Cancer Center will greatly improve the experience and outcomes for patients diagnosed with skin cancer, advancing AHN’s commitment to offering the most advanced, personalized care for patients.”

Patients interested in scheduling an appointment at the AHN Skin Cancer Center at West Penn Hospital can call 412-578-HOPE. The new center is on the hospital’s second floor the Mellon Pavilion of the hospital.

Media Contact

Emily Beatty, Allegheny Health Network, 5136789620, [email protected], www.ahn.org

SOURCE Allegheny Health Network

CMI Media Group Hires Danielle Koffer as Executive Vice President, Group Client Director


Koffer brings a wealth of experience and proven record of accomplishments and success in the healthcare marketing industry and beyond. With a distinguished career spanning over 20 years, she has held various leadership positions at prominent companies and has consistently demonstrated exceptional vision, strategic acumen, and a passion for driving innovation.

“We have wanted Danielle to be part of our team for some time now and her outstanding leadership and expertise will be invaluable in guiding us through our next phase of growth and development,” said Melissa Barnhart, Chief Client Officer of CMI Media Group.

“This is a company with a remarkable history of making a positive impact in healthcare marketing, and I look forward to using my skills and experience to support the clients that transform lives,” said Koffer.

Danielle has been recognized by the industry with several awards including Cynopsis’s Top Women in Media, Industrialist’s Next 50. She most recently served as Chief Client Officer at WPP’s Mindshare, where she was able to collaborate with CMI Media Group leadership on behalf of clients. Prior to that role she spent three years at Colgate Palmolive as VP, Global Marketing Communications, creating a future-proofed approach to transformative marketing.

CMI Media Group is WPP’s leading healthcare media specialist. The company has brought many firsts to healthcare marketing as the leading healthcare-focused media buying and planning resource to the world’s game changers in pharma and life sciences.

Those looking to join the CMI Media Group team can visit the company’s career page for more information and a link to apply: https://cmimediagroup.com/careers/

About CMI Media Group

CMI Media Group, a WPP company (NYSE: WPP, http://www.wpp.com), is a full-service global media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group’s core offerings include Audience Strategy, Planning, Development, and Insights; Data and Analytics; Buying and Investment; and Direct Response and Customer Experience. As the leading media resource for the world’s top healthcare companies, CMI Media Group brings together leading technology, data, and talent to deliver seamless capabilities for clients. CMI Media Group has been recognized as a leader in DE&I, talent retention and employee development as well as one of the industry’s best places to work.

Media Contact

Carly Kuper, CMI Media Group, 6107315409, [email protected], https://cmimediagroup.com/

SOURCE CMI Media Group

Wounded Warrior Project Partners with The Honor Foundation Once Again For 2023


“Wounded Warrior Project and THF share a common goal to build a network of support for our veterans. This grant is invaluable to the expansion of our programs and will aid in our ability to help change the lives of members of the SOF community and their families. We’re so grateful to WWP and the many years of support and partnership they have given us, and we know our continued collective work will help create a true ecosystem of support for our veterans,” says Matt Stevens, CEO of THF.

THF’s program helps SOF operators navigate the change from military to civilian life and careers through an executive-education style transition curriculum that combines one-on-one executive coaching and industry mentorship, three months of class instruction, and access to an elite, nationwide professional network. The servicemen and women that have matriculated through the program, over 2,200 to date, are infusing businesses, corporations, and communities with leadership, innovation, and service. WWP has long been an advocate for this work, and this grant strengthens each organization’s effort to help the special operations forces community succeed in their journey after active-duty service.

For more information about The Honor Foundation, its locations, and its mission, visit https://www.honor.org.

ABOUT THE HONOR FOUNDATION

The Honor Foundation (THF) is a career transition program for U.S. Special Operations Forces that effectively translates their elite military service to the private sector and helps create the next generation of corporate and community leaders. It achieves this through a three-month program which provides tailored executive education, one-on-one coaching, and access to a nationwide professional network. This program was built by the desire to serve others with honor for life, so that their next mission is always clear and continues to impact the world. Every step is dedicated to preparing these outstanding men and women to continue to realize their maximum potential during and after their service career. The Honor Foundation has 2,200+ graduates to date and has campuses in San Diego, CA; Virginia Beach, VA; Camp Lejeune, NC; Fort Liberty, NC; Eglin, FL; Tampa, FL; JBLM, WA; Fort Campbell, TN and a virtual program (THFv). The Navy SEAL Foundation is a Founding Partner of The Honor Foundation.

ABOUT WOUNDED WARRIOR PROJECT

Since 2003, Wounded Warrior Project® (WWP) has been meeting the growing needs of warriors, their families, and caregivers — helping them achieve their highest ambition. Learn more.

Media Contact

Emily Burkle, The Honor Foundation, 1 7602131300, [email protected], https://www.honor.org

SOURCE The Honor Foundation

Prominent Plastic Surgeon Dr. Erez Dayan from Reno, NV Selected as Grand Rounds Lecturer at Cornell/Columbia Plastic Surgery


With an unwavering commitment to innovation and patient-centric care, Dr. Erez Dayan has emerged as a leading authority in cutting-edge plastic surgery. During his upcoming lecture, titled “Advanced Use of Minimally Invasive Technology in Face and Body Contouring,” Dr. Dayan will delve into the intricacies of his pioneering methods. His groundbreaking techniques have revolutionized the field, offering patients unparalleled results with minimal downtime. Attendees can expect to gain invaluable insights into the latest advancements, as well as witness the transformative power of minimally invasive procedures.

“It is an honor to be invited to speak to colleagues and inspire the next generation of plastic surgeons,” says Dr. Erez Dayan.

More about Dr. Erez Dayan:

Dr. Erez Dayan completed his training at the elite Harvard Plastic Surgery program before earning a fellowship in aesthetic surgery at the world-class Dallas Plastic Surgery Institute. Dr. Dayan provides comprehensive aesthetic treatments for the face, breast and body, as well as reconstructive surgery. At his practice Avance Plastic Surgery Institute, which is located at located at 5588 Longley Lane in Reno, Nevada, Dr. Dayan offers cutting-edge technology, surgical procedures and a full range of aesthetic facial and body treatments. He also is medical director at EMET Medical Wellness, providing treatment, therapeutic protocols and wellness plans tailored completely to individual unique needs, backed by expert knowledge and cutting-edge science. To learn more about Avance Plastic Surgery Institute call 775-800-4444 or visit http://www.avanceplasticsurgery.com. For EMET Medical Wellness, please call 775.799.EMET(3638) or visit http://www.emetwell.com.

Media Contact

Dr. Erez Dayan, Avance Plastic Surgery Institute, 775-800-4444, [email protected], https://www.avanceplasticsurgery.com/ 

SOURCE Avance Plastic Surgery Institute

Renowned Beverly Hills Plastic Surgeon, Dr. John Anastasatos, Featured in MSN Article for Putting Athens, Greece on the Map for Plastic Surgery



Owner of Los Angeles Plastic Surgery, Dr. John Anastasatos, is a renowned plastic surgeon widely known for his expertise. For the last 15 years, he has run one of the largest and most successful plastic surgery clinics in Beverly Hills, CA, and since 2021 has been operating his own clinic in Athens, Greece.

LOS ANGELES, Nov. 2, 2023 /PRNewswire-PRWeb/ — Known for his exceptional surgical skills and compassionate approach to patient care, Dr. Anastasatos has recently been featured in an exclusive MSN article titled, “From Los Angeles To Athens – How Dr. John Anastasatos Put the Greek Capital On The Map For Plastic Surgery.” In this insightful piece, Dr. Anastasatos discusses the expansion of his practice and the challenge of establishing Athens as an international destination for top-tier plastic surgery. Having witnessed the demand, resources and unparalleled standards for plastic surgery in Beverly Hills, he recognized the opportunity to elevate the overall standard of experiences in Europe by bringing his wealth of experience and quality to Athens. Dr. Anastasatos has successfully utilized his Los Angeles clinic as a model, ensuring that the same level of excellence is delivered to his patients in the Greek capital. His practice offers advanced surgical aesthetic procedures, including his innovative percutaneous facelift, “scarless facelift”, endoscopic brow lift and facelift, lip-lift, high definition liposculpture, minimal incision breast augmentation, endoscopic abdominoplasty, body contouring and injectables. Patients from the US, Canada, Australia, Europe, the Middle East and Asia fly to the Athens clinic knowing they get the cutting-edge level of care they would get in Beverly Hills and at the same time enjoy an unforgettable luxurious experience recovering in Athens, Greece. Dr. Anastasatos’ commitment to excellence, his unwavering dedication to his patients and his ability to push boundaries have solidified his position as a leading plastic surgeon in both Beverly Hills and Athens. With his innovative techniques and unique approach, he continues to revolutionize the field of plastic surgery, leaving an indelible mark.

Phigenics announces a peer-reviewed research paper on a large-scale field study that highlights deficiencies of ISO 11731 compared to the novel novel method, PVT VIABLE®


The study found a 21% discrepancy comparing the ISO 11731 spread plate method to the novel method, PVT VIABLE® (Phigenics Validation Test- Viability Identification Assay by Legionella Enrichment). PVT VIABLE® is a patent-pending method developed by Phigenics that detects viable Legionella bacteria found in building water systems in as little as 72 hours, as opposed to the 7-14 day turnaround time of the ISO 11731 method. The process utilizes the accuracy of PCR and the dependability of enrichment culture in a hybrid assay to detect viable and viable but non-culturable (VBNC) Legionella in a water sample.

Author and inventor Leah Wickenberg states, “Until now, Legionella has been known to exist in the VBNC state, but detection methods were cumbersome. This publication highlights the need to include VBNC Legionella in developing water management programs and provides an accurate way to validate that hazardous conditions are being controlled.”

Phigenics is hosting a free webinar on November 8th for regulatory authorities, epidemiologists, and quality and infection control professionals to learn more about this study and PVT VIABLE®.

For a full copy of “Inaccuracies of the ISO 11731 Method for Environmental Validation of Legionella in Building Water Systems: Opportunities to Improve Sensitivity and Detect Viable but Non-Culturable Legionella” published in Microorganisms or to obtain more information on Legionnaires’ disease and Legionella testing services, go to
https://www.mdpi.com/2076-2607/11/1/94.

Media Contact

Kellen Utecht, Phigenics, 1-844-850-408, [email protected], https://info.phigenics.com/

SOURCE Phigenics

Building a Worldwide Movement for Cultures of Health and Well-being in the Workplace


The peer-reviewed program has helped organizations maximize workforce health and well-being while increasing organizational performance. With a proven track record of success in enhancing health, well-being, and safety in workplace environments, HealthNEXT is uniquely suited to take this transformative approach beyond borders.

Ray Fabius, President of HealthNEXT, said, “We are thrilled to be expanding our global reach and bringing our program to develop a culture of health and well-being to organizations around the world. From a global view to a domestic lens, HealthNEXT is shaping a future where workplaces thrive, employees flourish, and communities are healthier.”

Two noteworthy international healthcare organizations have already joined forces with HealthNEXT in this global endeavor. Cognate Health, in Ireland, and Positive Medicine, located in New Zealand, have embraced the culture of health and well-being philosophy. As part of this expansion, HealthNEXT is partnering with NEXTperts from Cognate and Positive Medicine to bring clinical reinforcement to the Culture of Health and Well-Being program. These experts will be equipped to offer the program to organizations globally, acting as ambassadors for positive change.

HealthNEXT’s impact extends beyond corporate boundaries. Research has consistently shown that organizations and companies that prioritize and sustain a culture of health and well-being not only see improvements in the health status of their employees but also experience reductions in healthcare costs. By influencing employees to make healthier choices, the ripple effect extends to their families, homes, and communities, creating a profound and lasting impact on public health.

About HealthNEXT

HealthNEXT is a visionary organization committed to transforming workplaces into benchmark centers of health, safety, and well-being. HealthNEXT’s evidence-based approach fosters cultures of health and well-being, improving employee health status, boosting productivity, and positively influencing communities. Through innovative programs and strategic partnerships, HealthNEXT empowers organizations to create lasting impacts on employee well-being and organizational success. Visit healthnext.com to learn more.

About Cognate Health

Cognate Health Limited was established in 2018 in Ireland and is a leading provider of occupational health services to various sectors, including construction, ICT, pharmaceutical, healthcare, agriculture, manufacturing, finance, public sector, and retail. Cognate Health has developed a network of occupational health physicians supporting services throughout Ireland. No matter where clients are in Ireland, the UK, or throughout Europe, Cognate Health can facilitate high-quality assessments with unparalleled service, helping employers cultivate a culture of health and organizational performance. Visit https://cognatehealth.ie/ for more information.

About Positive Medicine

Positive Medicine is a concept, philosophy, and experience that provides a clear structural framework for changing health beliefs and facilitating behavior change. It is founded on the Māori model of health, Te Whare Tapa Whā, which describes health as an integration of the four pillars of health: Physical Health, Psychological Health, Emotional Health, and Spiritual Health. The principles of Positive Medicine support intentional decision-making and enablement to provide people leaders with the mindset they require to create organizations that flourish. Visit https://positivemedicine.com/ for more information.

Media Contact

Ivor Kiwi, HealthNEXT, 1 (216)544-1408, [email protected], https://healthnext.com/

SOURCE HealthNEXT